Nl-Fr

View abstract

This abstract is assigned to session Commercial session by Horus Pharma 2
Presentation typeInvited
TitleOptimizing tolerance without compromising efficacy - Belgian experience with a preservative-free latanoprost
Conflict of interestNo
Authors 1
Last nameCOLLIGNON
InitialsN
DepartmentCHU Liège
top ^